[HTML][HTML] Breakthrough of extracellular vesicles in pathogenesis, diagnosis and treatment of osteoarthritis

Z Liu, Y Zhuang, L Fang, C Yuan, X Wang, K Lin - Bioactive Materials, 2023 - Elsevier
Osteoarthritis (OA) is a highly prevalent whole-joint disease that causes disability and pain
and affects a patient's quality of life. However, currently, there is a lack of effective early …

Molecular classification of knee osteoarthritis

Z Lv, YX Yang, J Li, Y Fei, H Guo, Z Sun, J Lu… - Frontiers in cell and …, 2021 - frontiersin.org
Knee osteoarthritis (KOA) is the most common form of joint degeneration with increasing
prevalence and incidence in recent decades. KOA is a molecular disorder characterized by …

Biomarkers of joint damage in osteoarthritis: current status and future directions

R Kumavat, V Kumar, R Malhotra… - Mediators of …, 2021 - Wiley Online Library
Osteoarthritis (OA) is a disease of the whole joint organ, characterized by the loss of
cartilage, and structural changes in bone including the formation of osteophytes, causing …

An evidence-based systematic review of human knee post-traumatic osteoarthritis (PTOA): timeline of clinical presentation and disease markers, comparison of knee …

CM Khella, R Asgarian, JM Horvath, B Rolauffs… - International Journal of …, 2021 - mdpi.com
Understanding the causality of the post-traumatic osteoarthritis (PTOA) disease process of
the knee joint is important for diagnosing early disease and developing new and effective …

[HTML][HTML] Osteoarthritis year in review: genetics, genomics, epigenetics

DA Young, MJ Barter, J Soul - Osteoarthritis and cartilage, 2022 - Elsevier
Objective In this review, we have highlighted the advances over the past year in genetics,
genomics and epigenetics in the field of osteoarthritis (OA). Methods A literature search of …

[HTML][HTML] Osteoarthritis in year 2021: biochemical markers

Y Henrotin - Osteoarthritis and cartilage, 2022 - Elsevier
Objective To summarize recent scientific advances in protein-derived soluble biomarkers of
osteoarthritis. Design A systematic search on the PubMed electronic database of clinical …

Biological strategies for osteoarthritis: from early diagnosis to treatment

AE Weber, IK Bolia, NA Trasolini - International orthopaedics, 2021 - Springer
Purpose To provide an updated review of the literature on the use of orthobiologics as a
potential treatment option to alleviate symptoms associated with osteoarthritis (OA), slow the …

Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression

IA Szilagyi, CL Vallerga, CG Boer, D Schiphof… - …, 2023 - academic.oup.com
Objectives The aim of this study was to identify biomarkers for radiographic OA severity and
progression acting within the inflammation and metabolic pathways. Methods For 3517 …

The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunities

H Kim, J Seo, Y Lee, K Park, TA Perry… - Therapeutic …, 2022 - journals.sagepub.com
In this narrative review article, we critically assess the current state of the osteoarthritis (OA)
drug development pipeline. We discuss the current state-of-the-art in relation to the …

Emerging technologies and platforms for the immunodetection of multiple biochemical markers in osteoarthritis research and therapy

E Bernotiene, E Bagdonas, G Kirdaite… - Frontiers in …, 2020 - frontiersin.org
Biomarkers, especially biochemical markers, are important in osteoarthritis (OA) research,
clinical trials, and drug development and have potential for more extensive use in …